Luc Mainville, CFO, acquired 150,000 Common Shares Class A on a direct ownership basis at a price of $0.667 on July 15th, 2021. This represents a $100,005 investment into the company's shares and an account share holdings change of 8.9%.
Valeo Pharma is in the Pharmaceuticals Sub Industry Group under the Healthcare Sector.
Valeo Pharma Inc is a Canada-based specialty pharmaceutical company dedicated to the commercialization of prescription products in Canada. With a focus on neurodegenerative diseases, woman's health, and oncology and supportive care, the Company has a portfolio of products and a platform to manage these products through stages of commercialization.
No Comments